Inventor · disambiguated record
Carl Brendan Doyle
Also filed as: DOYLE CARL BRENDAN
5 granted patents·2 pending applications·10 citations·filing 2016–2025
74Inventor score
Top patents by PatentIndex Score
7 records- 0188US11014979B2Anti-AP2 antibodies and antigen binding agents to treat metabolic disordersHARVARD COLLEGE·Filed 2018·Granted May 25, 2021·4 cites·35 claims
- 0285US12247068B2Anti-AP2 antibodies and antigen binding agents to treat metabolic disordersHARVARD COLLEGE·Filed 2021·Granted Mar 11, 2025·1 cites·19 claims
- 0382US10160798B2Anti-aP2 antibodies and antigen binding agents to treat metabolic disordersHARVARD COLLEGE·Filed 2016·Granted Dec 25, 2018·4 cites·48 claims
- 0474US10766956B2Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosisUCB BIOPHARMA SPRL·Filed 2017·Granted Sep 8, 2020·1 cites·11 claims
- 0573US2025346654A1Anti-ap2 antibodies and antigen binding agents to treat metabolic disordersHARVARD COLLEGE·Filed 2025·Application pending·0 cites
- 0658US11518803B2Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosisUCB Biopharma SRL·Filed 2020·Granted Dec 6, 2022·0 cites·20 claims
- 0756US2025026836A1Anti-hla-g antibodiesUCB Biopharma SRL·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carl Brendan Doyle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →